SCHEMBL7376591

SCHEMBL7376591

COc1cc(N)c(S)cc1C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.54
▸ KDM4E B2RXH2 4/20 0.50
▸ HPGD P15428 2/20 0.50
▸ LCK P06239 1/20 0.49
▸ FYN P06241 1/20 0.49
▸ GAA P10253 1/20 0.46
▸ HSD17B10 Q99714 2/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.42
▸ HTT P42858 3/20 0.40
▸ LMNA P02545 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ P2RX3 P56373 1/20 0.39
▸ P2RX2 Q9UBL9 1/20 0.39
▸ CA12 O43570 2/20 0.39
▸ CA1 P00915 2/20 0.39
▸ CA2 P00918 2/20 0.39
▸ CA4 P22748 2/20 0.39
▸ CA6 P23280 2/20 0.39
▸ CA7 P43166 2/20 0.39
▸ CA9 Q16790 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1965781 0.85 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDLCKFYN
SCHEMBL31634578 0.85 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDLCKFYN
SCHEMBL8901996 0.83 ALDH1A1 (0.55) ALDH1A1KDM4EHPGDLCKFYN
SCHEMBL9706363 0.83 ALDH1A1 (0.59) ALDH1A1KDM4EHPGDLCKFYN
SCHEMBL22691985 0.81 ALDH1A1 (0.58) ALDH1A1KDM4EHPGDLCKFYN
SCHEMBL23699524 0.81 TSHR (0.53) ALDH1A1KDM4EHPGDGAAHSD17B10
SCHEMBL5656466 0.80 ALDH1A1 (0.51) ALDH1A1KDM4EHPGDLCKFYN
SCHEMBL866041 0.80 LCK (0.59) ALDH1A1KDM4EHPGDLCKFYN
SCHEMBL2890743 0.79 ALDH1A1 (0.59) ALDH1A1KDM4EHPGDLCKFYN
SCHEMBL8901228 0.79 ALDH1A1 (0.59) ALDH1A1KDM4EHPGDLCKFYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3859804-B1 SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS CANON KK (JP) 2024-08-07 — — EP claimed
US-12245446-B2 Semiconductor device having quantum dots, display device, imaging system, and moving body CANON KABUSHIKI KAISHA (JP) 2025-03-04 — — US disclosed
CN-119504547-A Amisulpride preparation method of the composition 山东安弘制药有限公司 2025-02-25 — — CN disclosed
CN-118993969-B Industrial production method for amisulpride 广州市桐晖药业有限公司 2025-01-24 — — CN disclosed
CN-118993969-A Industrial production method for amisulpride 广州市桐晖药业有限公司 2024-11-22 — — CN disclosed
EP-3859804-B1 SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS CANON KK (JP) 2024-08-07 — — EP disclosed
CN-114230497-A Preparation method of 4-amino-5-ethylsulfonyl-2-methoxybenzoic acid 广东省科学院生物与医学工程研究所 2022-03-25 — — CN disclosed
CN-113285024-A Semiconductor device having quantum dots, display device, imaging system, and moving object 佳能株式会社 2021-08-20 — — CN disclosed
US-20210242416-A1 SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS, DISPLAY DEVICE, IMAGING SYSTEM, AND MOVING BODY CANON KABUSHIKI KAISHA (JP) 2021-08-05 — — US disclosed
EP-3859804-A2 SEMICONDUCTOR DEVICE HAVING QUANTUM DOTS CANON KABUSHIKI KAISHA (JP) 2021-08-04 — — EP disclosed
US-6187807-B1 ADMINISTERING (S)(-)-AMISULPRIDE OR SALT THEREOF FREE OF THE (R)-(+)-STEREOISOMER, TO ELICIT ANTIPSYCHOTIC PROPERTIES IN A PATIENT SANOFI-SYNTHELABO (FR) 2001-02-13 — — US disclosed
US-6169094-B1 ANTIPSYCHOTIC AGENTS SANOFI-SYNTHELABO (FR) 2001-01-02 — — US disclosed
WO-2000003740-A2 USE OF (S) (-)-AMISULPRIDE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF SCHIZOPHRENIA SANOFI-SYNTHELABO (FR) 2000-01-27 — — WO disclosed
US-4816471-A NERVOUS SYSTEM DISORDERS SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILLE-DE FRANCE (FR) 1989-03-28 — — US disclosed
US-4673686-A CNS MODIFIERS, ANTI-APOMORPHINE ANTIENETIC ACITIVTY/ SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLE DE L'ILE DE FRANCE (FR) 1987-06-16 — — US disclosed
EP-0055524-B1 BICYCLO (3,2,1) OCTYLBENZAMIDES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BEECHAM GROUP PLC (GB) 1984-10-17 — — EP disclosed
US-4410535-A ANTIEMETICS BEECHAM GROUP LIMITED (GB) 1983-10-18 — — US disclosed
US-4401822-A ANISEROTONINE AGENTS; APOMORPHINE ANTAGONIST SOCIETE DE'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE-DE FRANCE (FR) 1983-08-30 — — US disclosed
EP-0055524-A2 Bicyclo (3,2,1) octylbenzamides, a process for their preparation and pharmaceutical compositions containing them BEECHAM GROUP PLC (GB) 1982-07-07 — — EP disclosed
US-4294828-A ANTIEMETIC AND ANTISEROTONIN SOCIETE D'ETUDES SCIENTIFIQUES ET INDUSTRIELLES DE L'ILE DE-FRANCE (FR) 1981-10-13 — — US disclosed
Send feedback